Discover
LGND
Ligand Pharmaceuticals Incorporated
312.01
2 x 224.04
1 x 312.97
bid
ask
-
4.08
1.29%
2 @ 04:00 PM
310.00 -2.01 (0.64%)
| Ytd | 65.02% | |
| 1y | 177.19% |
305.31
day range
318.41
111.72
52 week range
320.99
| Open | 315.07 | Prev Close | 316.09 | Low | 305.31 | High | 318.41 | Mkt Cap | 6.25B |
| Vol | 457.47K | Avg Vol | 319.10K | EPS | 7.67 | P/E | 40.68 | Forward P/E | 27.57 |
| Beta | 1.04 | Short Ratio | 8.48 | Inst. Own | 106.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 07-02 | Earning | 08-06 | 50-d Avg | 242.73 | 200-d Avg | 206.59 | 1yr Est | 277.60 |
LGND News
seekingalpha.com
Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator
Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300
globenewswire.com
Ligand Announces Closing of Convertible Senior Notes Offering
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the pro
benzinga.com
Ligand Plans $550M Convertible Notes Offering, To Use Notes Sale for Share Buybacks and Corporate Ne
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ("Ligand") announced today its intention t
benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session